GENE ONLINE|News &
Opinion
Blog

LATEST
argenx’s Novel Treatment for Myasthenia Gravis gets FDA Nod
2021-12-21
Oracle Acquires Cerner to Expand Digital Healthcare Management Offerings
2021-12-21
ASH 2021: Engineering Stem Cells into Therapeutic Immune Cells
2021-12-21
Antengene’s XPO1 Inhibitor Receives First-In-Class Approval in China for Multiple Myeloma
2021-12-20
EMA Rejects Marketing Authorization Application of Aduhelm
2021-12-20
Experimental mRNA Vaccine Could Lead Fight Against HIV
2021-12-19
BMS’ Drug Wins First-In-Class Approval for Prevention of Acute Graft-Versus-Host Disease
2021-12-17
Daiichi Sankyo Authorizes First Yescarta Treatment Site in Japan
2021-12-17
ASH 2021: Understanding the Crosstalk between Acute Leukemia and Down Syndrome for Designing Better Therapies
2021-12-16
Australia’s CSL Makes $11.7 Billion Bid for Swiss Drugmaker Vifor
2021-12-15
Pfizer to Acquire Arena and its Immuno-Inflammatory Drug for $6.7 Billion
2021-12-14
A Digital Solution Tracks Pill Adherence with 98% Accuracy
2021-12-13
ASH 2021: 4 Immunotherapies Highlight Transformations in Blood Cancer Treatment
2021-12-13
Mental Healthcare Startup Cerebral Valued at $4.8 Billion after $300 Million Softbank-led Series C
2021-12-10
China’s Innoforce Bags $157 Million to Boost Cell, Gene and RNA CDMO Services
2021-12-10
1 104 105 106 107 108 218
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top